MENU

Papua New Guinea: Affected by circulating vaccine-derived poliovirus

23 Jun, 2018
, Source:

Circulation of vaccine-derived poliovirus type 1 (cVDPV1) has been confirmed in Papua New Guinea, with a case reported from Morobe province, as well as the same virus isolated from two healthy children from the same community. Surveillance for AFP cases is being strengthened and an outbreak response will be implemented.

The detection of cVDPVs underscores the importance of maintaining high levels of routine vaccination coverage at all levels to minimize the risk and consequences of any poliovirus circulation. A robust outbreak response is needed to rapidly stop the VDPV1 transmission. WHO will continue to evaluate the epidemiological situation and outbreak response measures being implemented.

Travel advice

WHO’s International Travel and Health recommends that all travellers to polio-affected areas be fully vaccinated against polio. Residents (and visitors for more than 4 weeks) from infected areas should receive an additional dose of OPV or inactivated polio vaccine (IPV) within 4 weeks to 12 months of travel.

This entry was posted on Saturday, June 23rd, 2018 at 10:41 am and is filed under Latest News.

Literature Literature archive

Baalen, S. van. 2018 Research Ethics 14(4), 1–17. https://doi.org/10.1177/1747016117750312
Lutz CS, Carr W, Cohn A, Rodriguez L. 2018 Vaccine Volume 36: 7445–7455

Videos Video archive

Key figures share their perspectives on a controversy that led to the suspension of Ebola vaccine clinical trials in Ghana.

Drs. Heidi Larson and Pauline Paterson of the Vaccine Confidence Project join episode 50 of the Public Health United podcast with Nina Martin, November 2017.

Drs. Larson and Paterson join a discussion on vaccine confidence at Hong Kong University.  September, 2015.

Subscribe to our mailing list

Click here to go to our GDPR-compliant signup form.

  • Recent Posts